Intravenous immunoglobulins in severe Guillian-Barre syndrome in childhood.
Indian J Pediatr
;
2003 Jul; 70(7): 541-3
Artículo
en Inglés
| IMSEAR
| ID: sea-79050
ABSTRACT
OBJECTIVE:
This is a retrospective analysis of 25 children with severe Guillain-Barre syndrome admitted to our PICU.METHOD:
All children were treated with intravenous immunoglobulins (IVIG) in a dose of 2 g/kg body weight over 2-5 days in addition to supportive and respiratory care. Seventeen children were elective admissions to the PICU whereas 8 children were transferred from other hospitals in a critical condition. Five of 8 of the late referrals died as compared to none of the elective admissions.RESULT:
All 8 of the late referrals required mechanical ventilation as against 3 of the 17 elective admissions. Mean duration of PICU stay in the late referrals was 27 days as compared to 15 days in the elective admissions.CONCLUSION:
The authors concur with previously published reports, that early use of IVIG could reduce the mortality and the need for intubation and mechanical ventilation.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Femenino
/
Humanos
/
Masculino
/
Niño
/
Preescolar
/
Estudios Retrospectivos
/
Inmunoglobulinas Intravenosas
/
Síndrome de Guillain-Barré
/
Lactante
Tipo de estudio:
Estudio observacional
Idioma:
Inglés
Revista:
Indian J Pediatr
Año:
2003
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS